This is how one ought to see, how things really are.
To be shaken out of the ruts of ordinary perception, to be shown for a few timeless hours, the outer and inner world, not as they appear to an animal obsessed with survival or to a human being obsessed with words and notions, but as they are apprehended directly and unconditionally by Mind at Largethis is an experience of inestimable value to everyone and especially to the intellectual.
These words, from Aldous Huxleys seminal book The Doors of Perception, signaled a crucial turn in the popular perception of hallucinogenic drugs and the direction of hallucinogenic drug research.
It is hard to imagine a sharper departure from the psychotomimetic paradigm than that espoused by Huxley in his book. Whereas previous research referred to the hallucinogenic phenomena as distortions and disorders, Huxley extolled the perceptual alterations of mescaline, declaring, This is how one ought to see, how things really are. While researchers noted the incoherent ramblings of patients undergoing LSD treatment, Huxley used hallucinogenic drug experiences as the basis for an articulate philosophical exploration, drawing inspiration from Meister Eckhart, the Buddha, Plato, Aquinas, Whitman, and Henri Bergson. In his view, psychedelics were not simply experimental tools that could be used to artificially induce a demented mind; Huxley recognized hallucinogens potential as tools for achieving a spiritual and philosophical experience of insurmountable value, not only for psychiatrists but also for artists, intellectuals, mystics, and anyone interested in exploring the secrets of existence.
A distinguished author and intellectual who gained international fame following the publication of his novel Brave New World, Huxleys immense enthusiasm for the intellectual and spiritual implications of hallucinogenic drugs would prove formative for the generation of psychedelic drug enthusiasts that subsequently changed the face of American society.
While researchers noted the incoherent ramblings of patients undergoing LSD treatment, Huxley used hallucinogenic drug experiences as the basis for an articulate philosophical exploration.
Relevantly, one might surmise that it was a difference in set and setting that was responsible for Huxleys new and highly divergent interpretation of hallucinogenic effects. Huxley, after all, had been an aspiring mystic for much of his life. He had cultivated a steady interest in Vedanta Hinduism since the end of the 1930s; his 1945 book The Perennial Philosophy, a comparative study of mystical traditions, argued for the universal compatibility of all spiritual systems. Huxleys unique perspective certainly contributed to the development of his perennial interpretation of the effects of psychedelics, which not only enlisted the teachings of mystics from various traditions but also interpreted the drugs as revealing a perennial type of knowledge, which he termed a Mind-at-Large. In addition, Huxleys profound interest in Eastern religions led him to his invocation of Eastern concepts and ideas as avenues through which one might explore and understand the effects of psychedelics, a thesis that had a profound impact on the subsequent exegesis of psychedelia. In sum, Huxleys religious interests placed him in the unique position of shifting the discourse by being one of the first Western thinkers to point to the potential religious importance of hallucinogens.
An additional factor that contributed to Huxleys unique set was his long-standing interest in mind-transforming substances, which ran all the way back to his early writing. By 1931, the English author had already published an essay, Wanted, a New Pleasure, in which he lamented humankinds scant advancements in fashioning new forms of pleasure over the course of the past millennia. So far as I can see, the only possible new pleasure would be one derived from the invention of a new drug, he asserted at the time. For Huxley, mind-altering drugs harbored a promise to quench a deep running thirst of human existence:
If we could sniff or swallow something that would, for five or six hours each day, abolish our solitude as individuals, atone us with our fellows in a glowing exaltation of affection and make life in all its aspects seem not only worth living, but divinely beautiful and significant, and if this heavenly world transfiguring drug were of such a kind that we could wake up the next morning with a clear head and an undamaged constitutionthen, it seems to me, all our problems (and not merely the one small problem of discovering a novel pleasure) would be wholly solved and earth would become paradise.
Read with the benefit of hindsight, these daring utopian propositions present us with an exceptionally prescient description of the 1960s psychedelic ideology epitomized in DuPonts company slogan, Better living through chemistry adopted and appropriated by the flower children some 30 years after it was first coined. It was a seed that gave birth to a whole branch of utopian psychedelic thought.
Huxleys fascination with the threat and promise of consciousness-altering chemicals constitutes a thread that runs through his writing. Brave New World features the fictional drug Soma, described in the novel as the perfect escapist drug. Huxleys Soma functions as a foremost agent for social engineering, a tool for the repression of the deeper longings and higher aspirations found in mans soul. This theme of psychochemical social engineering was further developed in Huxleys 1936 essay Propaganda and Pharmacology, which envisioned a future society subjected to a state of complacent hypnosis by the mass employment of powerful mind-control drugs. By contrast, Huxleys final work, the 1962 utopian novel Island, features another fictional drug, evidently inspired by Huxleys involvement with psychedelics. This drug, Moksha, could be seen as the mirror image of Soma: a fantastic agent for spiritual liberation that provides a full-blown mystical experience and stands at the foundation of the utopian society described in the novel.
In May 1953, psychiatrist Humphry Osmond spent a few days at the Huxley residence in Los Angeles with the author and his wife. Huxley, who was fascinated by the accounts of hallucinogenic drugs and their peculiar effects, had implored Osmond to allow him to experience these effects firsthand. Osmond was reluctant at first, worried that he might become infamous as the person who rendered the famous novelist insane. However, he eventually consented, and on May 4, 1953, Huxley had his first experience with mescaline.
The experience exceeded his wildest expectations. Huxley called it without question the most extraordinary and significant experience this side of the beatific vision. Gazing on the flower arrangement in the room, he felt that he was seeing what Adam had seen on the morning of his creation the miracle, moment by moment, of naked existence. The visual effects of the mescaline, previously labeled as distortions, turned Huxleys mind to classical art. Looking at a chair and then examining Van Goghs painting of a chair, he could not help but think that the chair Van Gogh had seen was obviously the same in essence as the chair I had seen; the folds and creases in his trousers, suddenly spectacularly detailed, seemed straight from a painting by Botticelli. He described his experiences with unbridled elation, using mystical concepts such as the Godhead and the beatific vision, and depicted a world in which mescaline and similar drugs would be used for intellectual and spiritual education. For Huxley, mescaline and drugs like it represented potential educational tools that could make it possible for young people to taste and see what they have learned about at second hand, or directly but at a lower level of intensity, in the writings of the religious or the works of poets, painters and musicians. Going back to his 1931 concept of a new drug that could salvage humanity, he wrote:
What is needed is a new drug which will relieve and console our suffering species without doing more harm in the long run than it does good in the short. Such a drug must be potent in minute doses and synthesizable. If it does not possess these qualities, its production, like that of wine, beer, spirits or tobacco will interfere with the raising of indispensable food and fibers. It must be less toxic than opium or cocaine, less likely to produce undesirable social consequences than alcohol or barbiturates, less inimical to heart and lungs than the tars and nicotine of cigarettes. And on the positive side, it should produce changes in consciousness more interesting, more intrinsically valuable than mere sedation or dreaminess, delusions of omnipotence or release from inhibitions. To most people, mescaline is almost completely innocuous. Unlike alcohol, it does not drive the taker into a kind of uninhibited action which results in brawls, crimes of violence and traffic accidents.
Mescaline was not yet the ideal drug. Huxley noted that along with the happily transfigured majority of mescaline takers there is a minority that finds in the drug only hell or purgatory. However, he was confident that modern chemistry and physiology were capable of achieving practically anything if the psychologists and sociologists will define the idea.
Huxleys Doors of Perception evoked a gamut of responses: some hostile, some sympathetic, some clearly bewildered. Several magazine writers noted that Huxleys radical ideas could easily be rejected as the fantasies of a misguided crackpot had they been presented by anyone other than the respected English author. Some magazines celebrated Huxleys proposition for a superior drug that could replace alcohol; others worried that the authors ruminations might inadvertently encourage undisciplined hordes of youths to experiment with drugs. Authors were notably disturbed by Huxleys association of the mescaline experience with Christian theology and mysticism. Stephen Siff, who has conducted an exhaustive review of media reactions to Huxleys essay, notes that Time magazine went as far as to skip the parts of Huxleys text that it considered potentially offensive to readers because of their Christian content. Particularly instructive was the response from some Central European intellectuals, who were quick to point out some of the ethical and cultural concerns that would resurface repeatedly in future discussions on psychedelics. German intellectual Thomas Mann described the book as a new and particularly scandalous stage of Huxleys escapism, arguing that Huxleys sympathetic treatment of experimentation with hallucinogens amounted to an encouragement to the youth of America to engage in doping, which they do not at all need. Another scathing critique came from Swiss psychoanalyst Carl Gustav Jung.
Huxleys Doors of Perception evoked a gamut of responses: some hostile, some sympathetic, some clearly bewildered.
In an April 1954 letter to Dominican priest Victor Francis White, Jung opined that there is no point in wishing to know more of the collective unconscious than one gets through dreams and intuitions. The renowned psychiatrist acknowledged the interest of mescaline, yet he was suspicious of experiencing it himself for fear of doing so out of idle curiosity. I should hate the thought that I had touched on the sphere where the paint is made that colours the world, where the light is created that makes shine the splendour of the dawn, the lines and shapes of all form, the sound that fills the orbit, the thought that illuminates the darkness of the void, he stated. In Jungs response, one can identify an often subterranean but nevertheless recurring notion in the LSD debate, one that frames the drugs ability to elicit spiritual experiences as an artificial and therefore immoral shortcut, defying celestial mandates. I am profoundly mistrustful of the pure gifts of the Gods. You pay very dearly for them, Jung warned, enlisting Virgils Aeneid to his side: (Men of Troy, beware the horse!) Whatever it is, I fear the Greeks, even bearing gifts. As for Huxley, he was described by Jung as a Zauberlehrling, a sorcerers apprentice who has learned how to call on ghosts but does not possess the knowledge needed to control them. It would be rash to proceed any further, the psychiatrist argued, before fully understanding the unconscious.
Though seldom fully articulated, Jungs negative estimation of Huxleys new pursuit was characteristic of many others opinions voiced on both sides of the Atlantic. The English author had become a suspicious eccentric in the eyes of many, a situation that he lamented with great bafflement and bitterness. However, as the years progressed, Huxleys views proved to be highly influential with a new generation of hallucinogenic drug researchers, as well as with the nascent psychedelics movement.
Ido Hartogsohn is Assistant Professor in the Graduate Program in Science, Technology, and Society at Bar Ilan University. He is the author of American Trip, from which this article is excerpted.
- Psychedelics Companies in Oregon Will Have to Grapple With 280E - Business Insider - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 16 - The Dales Report - May 21st, 2022
- Psychedelics and Mindfulness: The Future of Mental Health? | Microdose - Microdose Psychedelic Insights - May 21st, 2022
- CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend - Psychedelic Spotlight - May 21st, 2022
- 'I took ketamine to treat my severe depression' - iNews - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 9 - The Dales Report - May 15th, 2022
- Psychedelic Patents are Broken Because the Patent System Is Broken - VICE - May 15th, 2022
- Magic mushrooms are on WeHos mind - WEHOville - May 15th, 2022
- Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin - Technology Networks - May 15th, 2022
- Revitalist's Strategic Initiatives Continue to Exceed Expectations for Execution Giving Company Record High Revenues Since Opening in 2018. - Business... - May 15th, 2022
- MDMA as medicine: Stemming the tide of veteran suicides in Western North Carolina - Smoky Mountain News - May 15th, 2022
- Cybin's CYB0004 Shows Positive Preclinical Results Over ... - May 3rd, 2022
- Psychedelics played role in Wallace Falls hiker's death ... - May 3rd, 2022
- The Mainstream Healthcare VCs Dipping Their Toes Into Psychedelics - Business Insider - May 3rd, 2022
- LSD Is Back On Campus, But This Time It's Approved - Green Market Report - May 3rd, 2022
- Mixing mushrooms and alcohol: What you need to know - Medical News Today - May 3rd, 2022
- Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market - GlobeNewswire - May 3rd, 2022
- Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for... - May 3rd, 2022
- Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe - Forbes - April 15th, 2022
- Psilocybin Rewires the Brain for People with Depression - University of California, San Francisco - April 15th, 2022
- Field Trip Health Houston's psychedelic healing with ketamine helps patient with depressive anxiety - Houston Chronicle - April 15th, 2022
- Mental Health Week: Magnetic Stimulation, Psychedelics and Tai Chi How Treatments For Anxiety And Depression Are Growing - KPCC - April 15th, 2022
- Psychedelics Want To Win Over The Sleep Aid Market - Green Market Report - April 15th, 2022
- Terran Biosciences and Blumentech SL announce the acquisition of a patent portfolio covering the groundbreaking discoveries of prominent psychedelics... - April 15th, 2022
- Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds - Yahoo Finance - April 15th, 2022
- Experts discuss the intersections of cannabis, health and food - CSU Pueblo Today - April 15th, 2022
- Psychedelics - PMC - April 11th, 2022
- Psychedelics - PubMed - April 11th, 2022
- Peace with psychedelics: Palestinians, Israelis took ayahuasca - Big Think - April 11th, 2022
- Study maps psychedelic-induced changes in consciousness to specific regions of the brain - PsyPost - April 11th, 2022
- The Next Big Addiction Treatment - The New York Times - April 11th, 2022
- SABI Mind and Reverie Psychedelics Partner To Expand Research Into Psychedelic-Assisted Therapies - Benzi - Benzinga - April 11th, 2022
- Jaden Smith on His Trippy Summer '22 Collection and the Power of Mushrooms - Complex - April 11th, 2022
- Biomind Labs to Present at Benzinga Psychedelics Capital Conference in the U.S. on April 19th 2022 - Business Wire - March 31st, 2022
- Psychedelics' Interaction With Psych Meds: More Q's Than A's - Medscape - March 31st, 2022
- The Insights Psychedelics Give You Arent Always True - March 18th, 2022
- Stage Set for Psychedelics Stock Boom: Here's Where ... - March 18th, 2022
- SXSW stage is a collision of weed, metaverse, NFTs, acid and saving the planet - PitchBook News & Analysis - March 18th, 2022
- Jaden Smith Recalls His Experience With Psychedelic Mushrooms: Everything Just Becomes So Beautiful - Koimoi - March 18th, 2022
- Michigan Activists Submit Psychedelics Decriminalization ... - March 17th, 2022
- Psychedelics and the Future of Psychiatry - March 17th, 2022
- Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review - The Deep Dive - March 17th, 2022
- A Fully-Seated Audience Takes Post-Punk with the Psychedelic Furs - Cornell University The Cornell Daily Sun - March 17th, 2022
- 5 people who used psychedelics to treat PTSD describe their trips - Business Insider - March 15th, 2022
- What is Microdosing, and Does it Work? - The New York Times - March 15th, 2022
- Bolt's Breslow Teams With Psychedelics Founder on Crypto Pharma Startup - The Information - March 15th, 2022
- Enveric, University of Calgary to study psychedelic therapy - OutSourcing-Pharma.com - March 15th, 2022
- Psychedelic therapy integral to ancient societies may be coming to Pennsylvania - 90.5 WESA - March 15th, 2022
- The Bluntness Debuts The BLUNTNESS/100 Its Inaugural List of the 100 Most Influential People in Cannabis & Psychedelics - 69News WFMZ-TV - March 15th, 2022
- Former NFL Player Eben Britton On His New Book, And The Tools He Used To Rebuild His Life (Including Psychedelics) - The Dales Report - March 15th, 2022
- Made by Marlo: Max Ingersoll and the Meaning of Meditation - Harvard Independent - March 15th, 2022
- What are Psychedelics? - March 8th, 2022
- Get the Legal Psychedelics for Sale in the USA ... - March 8th, 2022
- Fireside Project manifests a $200K fund to improve access to careers in psychedelic health - TechCrunch - March 8th, 2022
- Oklahoma bill to study mental health effects of 'shrooms' advances - Oklahoman.com - March 8th, 2022
- Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel... - March 8th, 2022
- Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness - Benzinga - Benzinga - March 8th, 2022
- How My Drinking Was Used to Deny Me Treatment for Depression - Filter - March 8th, 2022
- Seelos Therapeutics: Year-End Results and Business Highlights Microdose - Microdose Psychedelic Insights - March 8th, 2022
- No worries: Severe anxiety disorders to get the Incannex, Monash Uni treatment via psychedelics within vir ... - Stockhead - March 8th, 2022
- Meet the 16 Most Influential Women Shaping the Future of Psychedelics - Business Insider - February 15th, 2022
- Psychedelics startups are taking on mental health - Fast Company - February 15th, 2022
- Psychedelics Are Trending: If You Are Seeing Psilocybin In The Headlines Everywhere, You Are Right! - Ben - Benzinga - February 15th, 2022
- Why theres a push to legalize psychedelic drug therapy in Missouri - KTVI Fox 2 St. Louis - February 15th, 2022
- Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders - Business Wire - February 15th, 2022
- Psychedelic-assisted therapy program coming to Vancouver Island University | CTV News - CTV News VI - February 15th, 2022
- Sponsor 'confident' cannabis banking will pass this year (Newsletter: February 14, 2022) - Marijuana Moment - February 15th, 2022
- Core One Labs' Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone... - February 15th, 2022
- IBN (InvestorBrandNetwork) Expands Collaboration With Microdose Psychedelic Insights to Serve as Official Media Sponsor for all 2022 Events - Yahoo... - February 9th, 2022
- Journey Colab Believes It Has The Formula For Addiction Treatment - The Dales Report - February 9th, 2022
- Psychedelics Without the Trip Could Be 'Healing Magic' for Mental Health - Singularity Hub - February 7th, 2022
- Utah Lawmakers Vote To Study Benefits Of Psychedelics In Treating Mental Health Disorders - Marijuana Moment - February 7th, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of January 31 - The Dales Report - February 7th, 2022
- Psychedelic Therapy and Suicide: A Myth Busted? - Medscape - February 7th, 2022
- Back to the future: Psychedelic drugs in ... - Harvard Health - February 1st, 2022
- Seattle Legalizes Psychedelics - The Seattle Medium - February 1st, 2022
- How to Change Your Mind - Wikipedia - February 1st, 2022
- The Psychedelic Drug Industry Appears To Have A New Sugar Daddy - The Dales Report - February 1st, 2022
- Increased psychedelic use during pandemic prompts new research - University of Miami - February 1st, 2022
- What Is Microdosing and Can It Help Mental Health? - PsychCentral.com - February 1st, 2022